Drug intelligence / Profile preview

hydroxymatairesinol lignan

Development stage
Unknown
Lead developer
Linnea
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Hydroxymatairesinol lignan (commonly abbreviated as 7-HMR or simply HMR) is a naturally occurring plant lignan found primarily in the knots of Norway spruce (Picea abies) and in various whole grains. It is a precursor to the mammalian enterolignan enterolactone. Hydroxymatairesinol exhibits several biological activities including anti-inflammatory, antioxidant, weak estrogenic/anti-estrogenic effects, and potential anticancer properties. Mechanistically, it acts as a phytoestrogen with much weaker activity than estradiol and can modulate hormone metabolism by inhibiting enzymes such as aromatase and 5α-reductase. Preclinical studies have shown neuroprotective effects in models of Parkinson’s disease by reducing neuroinflammation and slowing dopaminergic degeneration[2][3][5]. Clinical studies indicate that supplementation with hydroxymatairesinol can significantly reduce hot flashes in postmenopausal women[6][8], improve metabolic parameters such as body weight and fat accumulation[9], and may support cardiovascular health. The compound is rapidly absorbed orally and metabolized to enterolactone in humans.

Brand names
HMRlignan
Other names
hydroxymatairesinol7-hydroxymatairesinol lignanHMR lignan
02

Targets

SRD5A (Steroid 5-alpha-reductase)ER (Estrogen receptor)CYP19A1 (Aromatase)

Beyond the preview

Go deeper on hydroxymatairesinol lignan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydroxymatairesinol lignan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call